|
|
| Line 1: |
Line 1: |
| ==Overview==
| |
|
| |
|
|
| |
|
| |
| ==Transmission==
| |
|
| |
|
| |
|
| |
| ==Genetics==
| |
|
| |
|
| |
|
| |
| ==Pathogenesis==
| |
| B. anthracis, the causative agent of anthrax, is a spore-forming bacterium. The spores of B. anthracis, which can remain dormant in the environment for decades, are the infectious form, but vegetative B. anthracis rarely causes disease.<ref name="ShadomySmith2008">{{cite journal|last1=Shadomy|first1=Sean V.|last2=Smith|first2=Theresa L.|title=Anthrax|journal=Journal of the American Veterinary Medical Association|volume=233|issue=1|year=2008|pages=63–72|issn=0003-1488|doi=10.2460/javma.233.1.63}}</ref>
| |
| Spores introduced through the skin lead to cutaneous or injection anthrax; those introduced through the gastrointestinal tract lead to gastrointestinal anthrax; and those introduced through the lungs lead to inhalation anthrax. After entering a human or animal, B. anthracis spores are believed to germinate locally or be transported by phagocytic cells to the lymphatics and regional lymph nodes, where they germinate; or both.<ref name="Ross1957">{{cite journal|last1=Ross|first1=Joan M.|title=The pathogenesis of anthrax following the administration of spores by the respiratory route|journal=The Journal of Pathology and Bacteriology|volume=73|issue=2|year=1957|pages=485–494|issn=0368-3494|doi=10.1002/path.1700730219}}</ref>
| |
| B. anthracis begins producing toxins within hours of germination.<ref name="HannaIreland1999">{{cite journal|last1=Hanna|first1=Philip C.|last2=Ireland|first2=John A.W.|title=Understanding Bacillus anthracis pathogenesis|journal=Trends in Microbiology|volume=7|issue=5|year=1999|pages=180–182|issn=0966842X|doi=10.1016/S0966-842X(99)01507-3}}</ref>
| |
| Protective antigen (PA) and edema factor (EF) combine to form edema toxin (ET) and PA and lethal factor (LF) combine to form lethal toxin (LT). After binding to surface receptors, the PA portion of the complexes facilitates translocation of the toxins to the cytosol, in which EF and LF exert their toxic effects.<ref name="Moayeri2004">{{cite journal|last1=Moayeri|first1=M|title=The roles of anthrax toxin in pathogenesis|journal=Current Opinion in Microbiology|volume=7|issue=1|year=2004|pages=19–24|issn=13695274|doi=10.1016/j.mib.2003.12.001}}</ref>
| |
|
| |
| ==Gross Pathology==
| |
|
| |
|
| |
|
| |
| ==Microscopic Pathology==
| |
|
| |
|
| |
|
| |
|
| |
| ==Pathophysiology==
| |
| The bacterium normally remains in the [[endospore]] form in the soil, and can survive for decades in this state.
| |
|
| |
| Once ingested by a ruminant or placed in an open cut, the bacterium begins multiplying inside the animal or human and if not treated, has a fatal outcome. Most anthrax bacteria inside the body are destroyed by anaerobic bacteria that can grow without oxygen. The greater danger lies in the bodily fluids and blood that spills from the body and spill into the soil where the anthrax bacteria turn into a dormant protective spore form. Once formed, the spores are very hard to eradicate.
| |
|
| |
| The infection normally proceeds as follows: once the spores are inhaled they are transported through the air passages into the lungs. The spores are then picked up by macrophages in the lungs and are transported through lymphatics to the lymph nodes in the mediastinum. Damage caused by the anthrax spores and bacilli to the central chest cavity lungs can cause chest pain and difficulty breathing. Once in the lymph nodes, the spores germinate into active bacillus, that multiply, and eventually bursts the macrophage cell, releasing many more bacilli into the bloodstream which are transferred to the entire body. Once in the blood stream these bacilli release a tripartite toxin (composed of lethal factor, edema factor and protective antigen) which is known to be the primary agents of tissue destruction, bleeding, and death. If antibiotics are given too late, even if the antibiotics eradicate the bacteria, some people still will die because the toxins produced by the bacilli still remain in their system at lethal dose levels.
| |
|
| |
| In order to enter the cells, the toxins use another protein produced by ''B. anthracis'', protective antigen. Edema factor inactivates [[neutrophil]]s (a type of phagocytic cell) so that they cannot phagocytose bacteria. Historically, it was believed that lethal factor caused macrophages to make [[TNF-alpha]] and [[IL1B|interleukin 1, beta]] (IL1B), both normal components of the immune system used to induce an inflammatory reaction, ultimately leading to [[septic shock]] and death. However, recent evidence indicates that anthrax also targets endothelial cells (cells that lines serous cavities, lymph vessels, and blood vessels), causing vascular leakage (similar to hemorrhagic bleeding), and ultimately [[hypovolemic shock]] (low blood volume), and not only septic shock. In other words the patient bleeds to death internally.
| |
|
| |
| The virulence of a strain of anthrax is dependent on multiple factors, primarily the poly-D-glutamic acid capsule that protects the bacterium from phagocytosis by host neutrophils and its [[anthrax toxin|toxins]], edema toxin and lethal toxin.
| |
|
| |
|
| |
| === Mode of infection ===
| |
| Anthrax can enter the human body through the intestines ('''ingestion'''), lungs ('''inhalation'''), or skin ('''cutaneous''') and causes distinct clinical symptoms based on its site of entry. An infected human will generally be quarantined. However, anthrax does not usually spread from an infected human to a noninfected human. But if the disease is fatal the person’s body and its mass of anthrax bacilli becomes a potential source of infection to others and special precautions should be used to prevent more contamination. Unfortunately inhalation anthrax, if left untreated until obvious symptoms occur, will usually result in death if treatment is started too late.
| |
|
| |
| Anthrax is usually contracted by handling infected animals or their wool, germ warfare/terrorism or laboratory accidents.
| |
|
| |
| '''1) Pulmonary (pneumonic, respiratory, or inhalation) anthrax'''
| |
|
| |
| Respiratory infection initially presents with cold or flu-like symptoms for several days, followed by severe (and often fatal) respiratory collapse. If not treated promptly soon after exposure, before symptoms appear, inhalational anthrax is highly fatal, with near 100% mortality.<ref name="bravata">Bravata DM, Holty JE, Liu H, McDonald KM, Olshen RA, Owens DK (2006), Systematic review: a century of inhalation anthrax cases from 1900 to 2005, Annals of Internal Medicine; 144(4): 270–80.</ref> A lethal dose of anthrax is reported to result from inhalation of about 10,000–20,000 spores. <ref name="urlwww.medicinenet.com">{{cite web |url=http://www.medicinenet.com/script/main/art.asp?articlekey=18812&page=2 |title=www.medicinenet.com |format= |work= |accessdate=2012-08-31}}</ref> Like all diseases there is probably a wide variation to susceptibility with evidence that some people may die from much lower exposures; there is little documented evidence to verify the exact or average number of spores need for infection. Inhalation anthrax is also known as Woolsorters' disease or as Ragpickers' disease since these people often caught it. Other practices associated with exposure include the slicing up of animal horns for the manufacture of buttons, the handling of hair bristles used for the manufacturing of brushes, and the handling of animal skins. Whether these animal skins came from animals that died of the disease or from animals that had simply laid on ground that had spores on it is unknown. Anthrax is a very hard disease to eliminate since Anthrax spores are devilishly hard to kill and have been known to have reinfected animals over 70 years after burial sites of anthrax infected animals were disturbed. <ref>"Anthrax" by Jeanne Guillemin, University of California Press, 2001,ISBN 0-520-22917-7, pg. 3 </ref>
| |
|
| |
| '''<u>2) Gastrointestinal (gastroenteric) anthrax</u>'''
| |
| Gastrointestinal infection is most often caused by eating anthrax infected meat and is characterized by serious gastrointestinal difficulty, [[vomiting]] of blood, severe diarrhea, acute inflammation of the intestinal tract, and loss of appetite. Gastrointestinal infections can be treated but usually result in fatality rates of 25% to 60%, depending upon how soon treatment commences. <ref>{{cite web | title = Anthrax Q & A: Signs and Symptoms | work = Emergency Preparedness and Response | publisher = Centers for Disease Control and Prevention | date = 2003 | url = http://www.bt.cdc.gov/agent/anthrax/faq/signs.asp | accessdate = 2007-04-19 }}</ref>
| |
|
| |
| <u>'''3) Cutaneous (skin) anthrax'''</u>
| |
| [[Image:Milzbrand.jpg|thumb|left|250px|Anthrax skin lesion.]]
| |
| Cutaneous (on the skin) anthrax infection shows up as a boil-like skin lesion that eventually forms an ulcer with a black center (i.e., eschar). The black eschar often shows up as a large, painless necrotic ulcers (beginning as an irritating and itchy skin lesion or blister that is dark and usually concentrated as a black dot, somewhat resembling bread mold) at the site of infection. Cutaneous infections generally form within the site of spore penetration within 2 to 5 days after exposure. Unlike bruises or most other lesions, cutaneous anthrax infections normally do not cause pain. Cutaneous infection is the least fatal form of anthrax infection if treated. But without treatment, approximately 20% of all cutaneous skin infection cases may progress to [[toxemia]] and death. <ref>{{cite web | title = Anthrax Q & A: Signs and Symptoms | work = Emergency Preparedness and Response | publisher = Centers for Disease Control and Prevention | date = 2003 | url = http://www.bt.cdc.gov/agent/anthrax/faq/signs.asp | accessdate = 2007-04-19 }}</ref> Treated cutaneous anthrax is rarely fatal.<ref name="bravata"/>
| |